Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
MEDI0382, a GLP/glucagon receptor dual agonist, significantly reduces hepatic fat content in subjects with type 2 diabetes mellitus
Addiction Recovery Support: May aid in restoring brain chemistry during treatment
Journal of Physiology Paris 93:501504 Radeljak S, Seiwerth S, Sikiric P (2004) BPC 157 inhibits cell growth and VEGF signalling via the MAPK kinase pathway in the human melanoma cell line
They work through entirely different mechanisms with no shared receptor targets and no documented interactions
Mild side effects and potential risks, which should be referred to a doctor if they persist or worsen, include: pain, redness, or itching at the site of the injection mild diarrhea swelling sensation in the body More serious side effects, which require immediate medical attention, include: muscle cramps irregular heartbeat unusual weakness or tiredness swelling of the ankles or feet Severe reactions are very rare but require emergency intervention
Product Specifications Research Overview BPC-157, also written as BPC 157 or BPC157, is a synthetic pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), molecular formula CHNO and molecular weight 1419.53 g/mol
US$ 25.80
US$ 29.32
US$ 24.02
